Angiogenesis

Publisher: Springer Science and Business Media B.V.
Country: Netherlands · Western Europe
Type: journal
ISSN: 09696970

15737209

Scopus 2,713 SJR

Scopus Q1 SJR Q

WoS Q1 JCR Q

WoS 11,2 JIF

Scopus 111 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

SJR 2,713
Quartile Q1
H-Index 111
Cites/doc 9,01
Docs (3y) 138
Cites (3y) 1.149

Clarivate

Web of Science · JCR · 2025

JCR Q Q1
JIF 11,2
5Y JIF 9,2
JCI 1,98

WoS indexes

SCIE

Subject classification

Categories (SJR)

Cancer Research Q1
Clinical Biochemistry Q1
Physiology Q1

Areas

Biochemistry, Genetics and Molecular Biology

WoS categories

Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q1	Q1	2,713	11,2	9,2	1,98	Q1	111
2024	Q1	Q1	2,689	9,2	8	2,12	Q1	106
2023	Q1	Q1	3,289	9,2	8,5	2	Q1	106
2022	Q1	Q1	2,227	9,8	9,2	1,86	Q1	106
2021	Q1	Q1	1,056	10,7	9,4	1,94	Q1	106
2020	Q2	Q1	1,061	9,6	8,7	2,26	Q1	106
2019	Q2	Q1	0,839	9,8	7,3	1,95	Q1	106
2018	—	Q1	—	5,9	5,3	1,43	Q1	—
2017	Q1	Q1	2,177	4,4	4,9	1,18	Q1	106
2016	Q1	Q1	1,875	5,3	4,6	—	—	106
2015	Q1	Q1	2,245	4,3	4,5	—	—	106
2014	Q1	Q1	1,886	4,9	4,7	—	—	106
2013	Q1	Q1	1,899	4,4	5,2	—	—	106
2012	Q1	Q1	2,022	4	—	—	—	106
2011	Q1	Q1	3,417	6,1	—	—	—	106
2010	Q1	Q1	3,212	6,2	—	—	—	106

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year	Category	Edition	JCR Q (1997+)	JCI Q (1997+)	Rank
2025	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	3/100
2024	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	3/98
2023	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	3/96
2022	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	4/68
2021	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	4/67
2020	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	4/65
2019	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	3/65
2018	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	6/65
2017	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	Q1	10/65
2016	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	9/63
2015	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	11/63
2014	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	9/60
2013	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	10/65
2012	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	11/68
2011	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	6/68
2010	PERIPHERAL VASCULAR DISEASE	SCIE	Q1	—	6/68